Drug costs

How Payers Are Keeping Specialty Drug Costs Down

April 11, 2019

The real-world strategies used to manage the high cost of specialty meds.

The State of Drug Rebates

April 10, 2019

The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?

State Adopts “Netflix” Model to Pay for Hep C Drugs

January 30, 2019

Louisiana’s subscription model aims to rein in the hepatitis C epidemic in the state.

Midterm Election Results: 6 Ways Healthcare Could Change in 2019

December 06, 2018

Here’s how experts predict healthcare will unfold in 2019.

Top Barriers to Biosimilar Approval and Adoption in the U.S.

December 01, 2018

The biosimilar market is flourishing in Europe-why aren’t we seeing similar gains in the U.S.?

Four Biosimilar Growth Opportunities to Watch

November 13, 2018

The value and benefits of biosimilars are increasingly becoming more apparent. Here are four areas where they are growing the most.

One Strategy that Could Significantly Reduce Oncology Drug Costs

October 25, 2018

Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.

What Managed Care Organizations Should Do About High Cost Therapies

October 24, 2018

How can payers cope with new, ultra-expensive therapies?

What Health Orgs Should Do as Cancer Treatment Costs Increase

September 10, 2018

While promising new options keep entering the scene, high costs can be problematic to patients and healthcare organizations. Here are some ways to cope.

Seven Most Out-Of-Reach Drugs for Patients Due to High Costs

July 18, 2018

Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.

x